secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001193125-26-005531
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PRIME study: PreTRM blood test cuts preterm births <32 wks by 56%, NICU admissions by 20%
--------------------------------------------------------------------------------

- Randomized trial of 5,018 women: 56% fewer births <32 wks, 32% fewer <35 wks.
- 20% reduction in NICU admissions and neonatal morbidity odds.
- One NICU day saved per 4.2 patients screened; number needed to screen for NICU admission: 39.
- Study published in Pregnancy journal (Society for Maternal-Fetal Medicine).
- Jefferies fireside chat on Jan 9, 2026 at 8:30 am ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000119312526005531/0001193125-26-005531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000119312526005531/sera-20260107.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-005531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer